Page last updated: 2024-10-24

camostat and Orthomyxoviridae Infections

camostat has been researched along with Orthomyxoviridae Infections in 2 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Orthomyxoviridae Infections: Virus diseases caused by the ORTHOMYXOVIRIDAE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sato, K1
Hayashi, H1
Shimotai, Y1
Yamaya, M1
Hongo, S1
Kawakami, K1
Matsuzaki, Y1
Nishimura, H1
Lee, MG1
Kim, KH1
Park, KY1
Kim, JS1

Other Studies

2 other studies available for camostat and Orthomyxoviridae Infections

ArticleYear
TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
    Journal of virology, 2021, 10-13, Volume: 95, Issue:21

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Benzamidines; Cell Line; Cell Line, Tumor; Cells, Cu

2021
Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses.
    Archives of virology, 1996, Volume: 141, Issue:10

    Topics: Adaptation, Physiological; Amantadine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal;

1996